Daylight Photodynamic Therapy: At-Home Delivery
2024

At-Home Daylight Photodynamic Therapy for Actinic Keratoses

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): David Bajek, Andreas Lesar, Carol Goodman, Daniella Levins, Paul O'Mahoney, Marese O'Reilly, Susan Yule, Ewan Eadie, Sally Ibbotson, Alan Fleischer

Primary Institution: School of Medicine, University of Dundee

Hypothesis

Can the dPDT@home kit effectively treat actinic keratoses at home?

Conclusion

The dPDT@home kit allows patients to manage their actinic keratoses at home, reducing hospital visits, but requires further evaluation and support.

Supporting Evidence

  • Patients reported an average willingness score of 8.9/10 to use the kit again.
  • 81.25% of follow-up questionnaires were returned.
  • Patients expressed doubts about the treatment's efficacy, averaging a score of 6.9/10.
  • Four out of six patients in the pilot group reported good treatment results.

Takeaway

This study tested a kit that lets people treat their skin problems at home using sunlight, which is easier and saves trips to the hospital.

Methodology

Patients used the dPDT@home kit for two treatments spaced three weeks apart, followed by questionnaires to assess their experience and treatment outcomes.

Potential Biases

Potential bias in self-reported outcomes and patient selection.

Limitations

The study had a small sample size and relied on patient self-administration, which may affect treatment outcomes.

Participant Demographics

Participants ranged in age from 53 to 84 years, with a mix of genders.

Digital Object Identifier (DOI)

10.3390/jcm13247745

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication